1. Home
  2. ANGI vs EOLS Comparison

ANGI vs EOLS Comparison

Compare ANGI & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$7.02

Market Cap

266.7M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.10

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
EOLS
Founded
1995
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.7M
284.3M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
ANGI
EOLS
Price
$7.02
$4.10
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$17.00
$15.50
AVG Volume (30 Days)
994.6K
834.3K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
1242.86
1.23
EPS
0.94
N/A
Revenue
$736,386,000.00
$297,176,000.00
Revenue This Year
$3.25
$13.27
Revenue Next Year
$3.76
$17.62
P/E Ratio
$7.39
N/A
Revenue Growth
47.60
11.61
52 Week Low
$6.43
$3.86
52 Week High
$19.42
$12.28

Technical Indicators

Market Signals
Indicator
ANGI
EOLS
Relative Strength Index (RSI) 38.45 39.98
Support Level $6.43 $4.02
Resistance Level $8.19 $4.99
Average True Range (ATR) 0.38 0.22
MACD 0.09 -0.04
Stochastic Oscillator 34.38 21.43

Price Performance

Historical Comparison
ANGI
EOLS

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: